P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Acadia acquires global rights to Trofinetide

Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome – Expanded agreement follows Acadia’s April 2023 U.S. launch of DAYBUE™ (trofinetide) as the first and only… Read More

Run4Rett – Save the Date

Mark your Calendars for our Annual SUNDAY 24th, 2023 New Location Richvale Community Centre, 160 Avenue Road, Richmond Hill, Ontario, L4C 5L8 Stay connected with Ontario Rett syndrome Association for more details. Feel free to sign-up for our… Read More